Skip to main content
The BMJ logoLink to The BMJ
. 1988 Nov 12;297(6658):1240–1241. doi: 10.1136/bmj.297.6658.1240

Pulmonary toxicity of malaria prophylaxis.

A C Davidson 1, C Bateman 1, C Shovlin 1, M Marrinan 1, G H Burton 1, I R Cameron 1
PMCID: PMC1834720  PMID: 3145065

Full text

PDF
1240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buser P., Räber J. Eosinophiles Lungeninfiltrat unter Malariaprophylaxe mit Pyrimethamin-Sulfadoxin (Fansidar). Schweiz Med Wochenschr. 1985 Aug 24;115(34):1174–1176. [PubMed] [Google Scholar]
  2. McCormack D., Morgan W. K. Fansidar hypersensitivity pneumonitis. Br J Dis Chest. 1987 Apr;81(2):194–196. doi: 10.1016/0007-0971(87)90140-9. [DOI] [PubMed] [Google Scholar]
  3. Murphy R. L., Phair J. P. Systemic reaction to pyrimethamine-sulfadoxine. J Fam Pract. 1986 Apr;22(4):375–376. [PubMed] [Google Scholar]
  4. Svanbom M., Rombo L., Gustafsson L. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar). Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1876–1876. doi: 10.1136/bmj.288.6434.1876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Whitfield D. Presumptive fatality due to pyrimethamine-sulfadoxine. Lancet. 1982 Dec 4;2(8310):1272–1272. doi: 10.1016/s0140-6736(82)90121-0. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES